Pill may cut HIV risk as much as 99%
Daily use of a pill approved to protect against HIV infection cuts a man's risk of getting the virus by 99%, a new study indicates. The research also offers the first evidence that even imperfect adherence to the treatment regimen can provide a big reduction in the risk of acquiring the virus, which causes AIDS. This article courtesy of the Gladstone Institutes and World Science staff.
Participants in the research were found to be able to cut their HIV infection risk by 76% merely by taking two doses a week.
The study, published in the 12 September online issue of the research journal Science Translational Medicine, examines the effectiveness of a FDA-approved drug known as tenofovir disoproxil fumarate (brand name Truvada). Read the article.